1
TITLE: ENDURANCE-2: Safety and Efficacy of ABT-493/ABT-530 in Hepatitis C Virus Genotype 2-infected Patients without Cirrhosis, a Randomized, Double-Blind, Placebo-Controlled Study  Full Text
AUTHORS: Kris V Kowdley; Massimo Colombo; Neddie Zadeikis; Parvez S Mantry; Filipe Calinas; Humberto I Aguilar; Victor de Ledinghen; Yves J Horsmans; Yiran R Hu; Teresa Ng; Federico Mensa;
PUBLISHED: 2016, SOURCE: 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) in HEPATOLOGY, VOLUME: 64
INDEXED IN: WOS
2
TITLE: ENDURANCE-4: Efficacy and Safety of ABT-493/ABT-530 Treatment in Patients with Chronic HCV Genotype 4, 5, or 6 Infection  Full Text
AUTHORS: Tarik Asselah; Christophe Hezode; Neddie Zadeikis; Magdy Elkhashab; Massimo Colombo; Rui T Marinho; Kosh Agarwal; Frederik Nevens; Ran Liu; Teresa Ng; Federico Mensa;
PUBLISHED: 2016, SOURCE: 67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) in HEPATOLOGY, VOLUME: 64
INDEXED IN: WOS